Vaxcyte, Inc. (PCVX)
NASDAQ:PCVX

Vaxcyte (PCVX) Stock Investors

125 Followers
Based on 647,628 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold PCVX
On average, investors allocate 2.15% of their portfolios to PCVX
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Positive
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 647,628 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding PCVX

0.7%
Last 7
Days
3.3%
Last 30
Days
Percentages indicate the change in the number of portfolios holding PCVX, out of 647,628 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

PCVX Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Increased
0.78%
$45.74
Based on the activity of 12,140 investors who made their portfolios public
The table shows changes in PCVX in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

PCVX Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Snowflake
3.87%
+2.44%
+3.62%
$48.75B
Technology
Nikola
5.38%
-0.74%
-2.12%
$409.24M
Energy
CVS Health
4.04%
+0.64%
+5.28%
$86.72B
Healthcare
Moderna
5.63%
-0.17%
+0.10%
$48.12B
Healthcare
Marvell
5.03%
+5.85%
+4.69%
$56.14B
Technology
Twilio
3.10%
+0.42%
+0.46%
$11.05B
Technology
Datadog
3.59%
+0.21%
+0.67%
$29.97B
Technology
Unity Software
3.56%
-0.13%
+1.06%
$10.47B
Technology
Cloudflare
4.02%
+0.15%
+0.96%
$20.29B
Technology
Trade Desk
4.90%
+0.26%
+1.11%
$33.08B
Technology
Based on the activity of 647,628 active portfolios
Open your Smart Portfolio

PCVX Investor Analysis

PCVX investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
17.1%
of PCVX holders
are under 35
Average Segment Performance
Average P/E Ratio37.63
Beta4.97
Dividend Yield5.14%
PCVX investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
51.4%
of PCVX holders
are between 35–55
Average Segment Performance
Average P/E Ratio40.55
Beta4.92
Dividend Yield6.17%
PCVX investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
31.4%
of PCVX holders
are over 55
Average Segment Performance
Average P/E Ratio40.40
Beta0.42
Dividend Yield5.67%
Overview of age group and performance of PCVX stock investors
See who invests in PCVX according to age group and performance.

FAQ

How many retail Investors hold PCVX?
<0.1% of TipRank’s retail investors hold PCVX in their portfolios.
    What is PCVX Investor Sentiment?
    PCVX’s Investor Sentiment is Very Positive.
      What percentage of retail investors changed their holding of PCVX in the last 7 days?
      ▲ 0.7% of TipRank’s retail investors changed their holding of PCVX in the last 7 days.
        What percentage of retail investors changed their holding of PCVX in the last 30 days?
        ▲ 3.3% of TipRank’s retail investors changed their holding of PCVX in the last 30 days.
          What is the average age of retail investors who hold PCVX?
          The average age of PCVX Holders is between 35–55.
            What other stocks have PCVX investors also bought?
            PCVX Investors also bought SNOW, NKLA, CVS, MRNA, MRVL, TWLO, DDOG, U, NET, TTD.

              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ACADACADIA Pharmaceuticals
              ABCAmerisourceBergen
              BCRXBioCryst
              BLRXBioline RX Ltd Sponsored ADR
              BIOBio-Rad Laboratories

              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis